SoInCell™
Cell Screening Platform
SoInCell™
Cell Screening Platform
Data-Empowered Cell Therapy Development.
Advancing Standards through Evidence-Based Screening.
Integrating high-throughput screening with multi-omics data analysis, the platform constructs a comprehensive stem cell functional map, predicting differentiation potential, tumorigenic risk, and in vivo efficacy. Backed by tens of millions of real-world data points, the platform reduces R&D timelines by 40% and doubles success rates.
-
High-Efficiency Screening
Automated culture combined with intelligent recognition processes tens of thousands of cell samples daily. -
Multi-Omics Integration
Integrates transcriptomic, proteomic, and metabolomic data to construct a comprehensive cell functional landscape. -
Intelligent Prediction
Predicts differentiation potential, tumorigenic risk, in vivo homing efficiency, and persistence. -
Data Scale
Tens of millions of real-world data points accumulated, covering MSC, TSPC, iPSC, NK, and other cell types. -
Efficiency Leap
R&D timelines reduced by 40%; clinical translation success rates doubled. -
Standard Leadership
Core participant in the development of industry standards including the Clinical Application Guidelines for Tendon Stem Cells.
SoInCell™
Cell Screening Platform
SoInCell™
Cell Screening Platform
Data-Empowered Cell Therapy Development.
Advancing Standards through Evidence-Based Screening.
Integrating high-throughput screening with multi-omics data analysis, the platform constructs a comprehensive stem cell functional map, predicting differentiation potential, tumorigenic risk, and in vivo efficacy. Backed by tens of millions of real-world data points, the platform reduces R&D timelines by 40% and doubles success rates.
-
High-Efficiency Screening
Automated culture combined with intelligent recognition processes tens of thousands of cell samples daily. -
Multi-Omics Integration
Integrates transcriptomic, proteomic, and metabolomic data to construct a comprehensive cell functional landscape. -
Intelligent Prediction
Predicts differentiation potential, tumorigenic risk, in vivo homing efficiency, and persistence. -
Data Scale
Tens of millions of real-world data points accumulated, covering MSC, TSPC, iPSC, NK, and other cell types. -
Efficiency Leap
R&D timelines reduced by 40%; clinical translation success rates doubled. -
Standard Leadership
Core participant in the development of industry standards including the Clinical Application Guidelines for Tendon Stem Cells.
Regenerative Medicine Cell Therapy Pipeline
Regenerative Medicine Cell Therapy Pipeline
Candidate |
Indication |
Drug Design & Screening |
CMC/IIT |
IND |
Phase I/II/III |
NDA |
Commercial Rights |
|---|---|---|---|---|---|---|---|
| SunRay001 > | |||||||
| SunRay001Key Component | | Rotator Cuff Tears, Achilles Tendon Injuries, Tendinopathy |
|
 |
||||
SUNRAY R&D Pipeline
SUNRAY R&D Pipeline
SunRay001
-
SunRay001
Allogeneic Tendon Stem Cell Injection (TSPC)
An allogeneic tendon stem/progenitor cell formulation, administered via ultrasound-guided local injection, differentiates into tenocytes and secretes extracellular matrix, aiming to promote functional tendon regeneration.
Mechanism of Action
Stem cells home to the injury site, differentiate into tenocytes, secrete extracellular matrix, and reconstruct the tendon microstructure, aiming to support functional healing
Unmet Need
Post-surgical retear rates remain high; existing therapies have limitations in restoring native tendon function, and patients may face repeated surgeries and decline in motor capacity
Current Status
The tendon stem cell IIT clinical trial has been approved and initiated at the Second Affiliated Hospital of Zhejiang University, with follow-up expected to complete by the end of 2026; a serum-free medium specifically developed for tendon stem cells has been developed in parallel
